Corporate Social Responsibility in Health Technology Industry Prior and during the Covid-19 Pandemic, in Greece

Corporate Social Responsibility (CSR) activities have been revealed as an emerging managerial tool and research field. The socioeconomic impact of the COVID-19 pandemic has prompted several companies to take on CSR initiatives. objective this study was investigate initiatives implemented in specializing pharmaceutical biomedical products well medical equipment, prior during pandemic. A cross-sectional conducted Hellenic Association Pharmaceutical Companies (SFEE), Panhellenic Industry (PEF) Health-Research Biotechnology (SEIV). self-administered questionnaire distributed a total 112 companies. Descriptive multivariate statistical analyses were performed using SPSS 25.0. Levels significance two-tailed set at p = 0.05. final sample consisted 74 with response rate 77.7%. Among them 62.2% multinational 37.8% national Some provided pharmaceuticals (40.5%), equipment biotechnology (32.4%) others both categories (27.1%). percentage equal 89.2% stated that they activities, out which 75.7% carried related initiatives, such public health (37.7%), societal issues (27.2%), environment (19.9%), etc. Approximately 50% increased their Moreover, majority devoted ≤30% budget against higher company’s turnover, performance. Greece actions, contributed handle effects crisis through Covid-19 differentiated according culture wealth. It is important authorities should reward carrying given positively contribute recovery by financially supporting care sector overall economy.